International Journal of Health and Clinical Research

International Journal of Health and Clinical Research

Comparative study of dorzolamide and latanoprost on intraocular pressure reduction in patient with age 30-50 years

Yazarlar: Amit Kumar Jha, Asha Kumari

Cilt 4 , Sayı 19 , 2021 , Sayfalar 382-384

Konular:-

Anahtar Kelimeler:Dorzolamide,Latanoprost,Anti Glaucoma effect.

Özet: Anti Glaucoma agents used for reduction of intraocular pressure. The present work carried out to compare effect of dorzolamide and and latanoprost on intraocular pressure reduction in patient with age 30-50 years”. In present work done by me Anti Glaucoma effect of drugs namely dorzolamide and latanoprost was compared with the control and with each other. Analysis of variance and student t-Test, ANOVA where applied to compare the result. It was found dat intraocular pressure. varied significantly across the three group (p=.000) compared to control group intraocular pressure was significantly less in both dorzolamide and latanoprost groups (p=.000) reduction of intraocular pressure with dorzolamide was less in compression to that of latanoprost (p=.011) and the end of work. latanoprost is more efficacious than dorzolamide as far as intraocular pressure reduction is concerned.


ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır

KAYNAK GÖSTER
BibTex
KOPYALA
@article{2021, title={Comparative study of dorzolamide and latanoprost on intraocular pressure reduction in patient with age 30-50 years}, volume={4}, number={382–384}, publisher={International Journal of Health and Clinical Research}, author={Amit Kumar Jha,Asha Kumari}, year={2021} }
APA
KOPYALA
Amit Kumar Jha,Asha Kumari. (2021). Comparative study of dorzolamide and latanoprost on intraocular pressure reduction in patient with age 30-50 years (Vol. 4). Vol. 4. International Journal of Health and Clinical Research.
MLA
KOPYALA
Amit Kumar Jha,Asha Kumari. Comparative Study of Dorzolamide and Latanoprost on Intraocular Pressure Reduction in Patient with Age 30-50 Years. no. 382–384, International Journal of Health and Clinical Research, 2021.